Navidea Biopharmaceuticals Inc (OP: NAVB )

0.0001 -0.0009 (-90.00%)
Streaming Delayed Price Updated: 9:30 AM EST, Nov 29, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
March 07, 2018
Form EFFECT
Source: SEC/Edgar
December 26, 2017
Form S-3
Source: SEC/Edgar
December 14, 2017
Form 8-K
Source: SEC/Edgar
December 14, 2017
Form 8-K
Source: SEC/Edgar
October 12, 2017
Form CT ORDER
Source: SEC/Edgar
March 26, 2017
Form NT 10-K
Source: SEC/Edgar
March 15, 2017
Form SC 13G
Source: SEC/Edgar
March 12, 2017
Form 8-K
Source: SEC/Edgar
March 12, 2017
Form 8-K
Source: SEC/Edgar
March 08, 2017
Form 8-K
Source: SEC/Edgar
March 01, 2017
Form 8-K
Source: SEC/Edgar
February 22, 2017
Form 8-K
Source: SEC/Edgar
February 15, 2017
Form 8-K
Source: SEC/Edgar
February 09, 2017
Form DEFM14A
Source: SEC/Edgar
February 07, 2017
Form PRER14A
Source: SEC/Edgar
January 29, 2017
Form PRER14A
Source: SEC/Edgar
January 12, 2017
Form PREM14A
Source: SEC/Edgar
December 04, 2016
Form 8-K
Source: SEC/Edgar
November 29, 2016
Form 8-K
Source: SEC/Edgar
November 02, 2016
Form 8-K
Source: SEC/Edgar
September 26, 2016
Form 8-K
Source: SEC/Edgar
September 05, 2016
Form 8-K
Source: SEC/Edgar
August 30, 2016
Form 8-K
Source: SEC/Edgar
August 10, 2016
Form NT 10-Q
Source: SEC/Edgar
August 09, 2016
Form 8-K
Source: SEC/Edgar
August 03, 2016
Form 8-K
Source: SEC/Edgar
July 17, 2016
Form DEF 14A
Source: SEC/Edgar
June 30, 2016
Form DEFA14A
Source: SEC/Edgar
June 30, 2016
Form 8-K
Source: SEC/Edgar
June 28, 2016
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.